|
Real-time Estimate
Cboe BZX
19:12:37 08/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 1.125 USD | +4.17% |
|
+4.63% | -32.34% |
| 08-07 | Lineage Cell Therapeutics, Inc., Q2 2026 Earnings Call, Aug 06, 2026 | |
| 08-06 | Lineage Cell Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Stock exchange
NYSE
LCTX 1.125 $
+4.17%
1.16M
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| LCTX | 1.125USD | +4.17% | 1.16M $ | ||
CBOE
| LCTX | 1.125USD | +3.69% | 13.27K $ | |
|
TEL AVIV STOCK EXCHANGE
| LCTX | 342.90ILa | +5.38% | 2.76M ILa | |
|
Tradegate
| BT3 | 0.9450EUR | +2.27% | 48.2 € | |
|
Deutsche Boerse AG
| BT3 | 0.9110EUR | 0.00% | 0 € | |
|
Börse Stuttgart
| BT3 | 0.9580EUR | +5.16% | 0 € | |
|
Boerse Muenchen
| BT3 | 0.9570EUR | +0.95% | 0 € |
Quotes 5-day view: Lineage Cell Therapeutics, Inc.
Delayed Quote NYSE
| 01/09/2026 | 02/09/2026 | 03/09/2026 | 04/09/2026 | 08/09/2026 | |
|---|---|---|---|---|---|
| Last | $1.080 | $1.110 | $1.100 | $1.080 | $1.125 |
| Volume | 905,661 | 675,975 | 917,013 | 535,726 | 1,033,258 |
| Change | -1.82% | +2.78% | -0.90% | -1.82% | +4.17% |
| Opening | $1.100 | $1.080 | $1.110 | $1.090 | $1.100 |
| High | $1.120 | $1.135 | $1.120 | $1.105 | $1.160 |
| Low | $1.080 | $1.080 | $1.085 | $1.080 | $1.091 |
Performance
| 1 day | +4.17% | ||
| 1 week | +4.63% | ||
| Current month | +2.73% | ||
| 3 months | -6.61% | ||
| 6 months | -36.16% | ||
| Current year | -32.34% | ||
| 1 year | -8.87% | ||
| 3 years | -16.91% | ||
| 5 years | -54.25% | ||
| 10 years | -67.62% |
Volumes
marketsDaily volume
1,033,232
Estimated daily volume
2,504,675
Avg. Volume 20 sessions
844,843
Daily volume ratio
2.96
Avg. Volume 20 sessions USD
950,448.38
Record volume 1
23,661,485
Record volume 2
22,539,712
Record volume 3
17,430,494
Capital turnover ratio
0
Float rotation
0
Basic data
Market Cap (USD)
273,140,061
Net sales (USD)
14,556,000
Number of employees
75
Sales / Employee (USD)
194,080
Free-Float
95.14 %
Free-Float capitalization (USD)
259,865,411
Average Daily Capital Traded
0.35%
Indicators
Moving average 5 days
1.094
Moving average 20 days
1.098
Moving average 50 days
1.152
Moving average 100 days
1.254
Price spread / (MMA5)
-2.76%
Price spread / (MMA20)
-2.40%
Price spread / (MMA50)
+2.42%
Price spread / (MMA100)
+11.45%
STIM
RSI 9 days
48.81
RSI 14 days
47.84
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.17% | +4.63% | -8.87% | -16.91% | 273M | |
| -0.82% | -3.77% | -2.49% | +14.92% | 48.41B | |
| +0.52% | +1.30% | +417.75% | +561.86% | 45.01B | |
| -1.33% | +1.89% | +40.25% | +23.28% | 44.07B | |
| -2.63% | -2.85% | +0.58% | +80.89% | 40.73B | |
| -1.72% | -3.07% | +13.76% | +43.40% | 33.21B | |
| -0.77% | +3.12% | - | - | 17.77B | |
| +0.08% | +1.40% | +20.18% | +118.14% | 16.5B | |
| -0.56% | -0.50% | +11.39% | +31.41% | 14.45B | |
| -1.60% | +0.46% | +75.09% | +42.01% | 13.77B | |
| Average | -0.42% | -0.09% | +63.07% | +99.89% | 27.42B | |
| Weighted average by Cap. | -0.95% | -0.13% | +87.62% | +135.53% |
Historical Quotes: Lineage Cell Therapeutics, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
d7249df.Bs4DQWzpKXoP4gU7y1-wwUVxjfN2yo7O2HkKFw2f9J0.bKZpF1TbegttjGx68mvVhx1BvpohveSp7D56f3fHxP9_vGAHFqp5ElqEZg
| Date | Price | Volume | Total |
|---|---|---|---|
| 19:10:47 | 1.125 | 200 | 867,408 |
| 19:10:09 | 1.125 | 200 | 867,208 |
| 19:09:41 | 1.128 | 650 | 867,008 |
| 19:09:41 | 1.128 | 700 | 866,358 |
| 19:09:41 | 1.128 | 100 | 865,658 |
| 19:09:41 | 1.130 | 650 | 865,558 |
| 19:09:41 | 1.130 | 100 | 864,908 |
| 19:09:23 | 1.130 | 150 | 864,808 |
| 19:09:23 | 1.130 | 150 | 864,658 |
| 19:09:23 | 1.130 | 804 | 864,508 |
Price Extremes
| 1 week | 1.08 |  | 1.16 |
| 1 month | 1.04 | | 1.18 |
| Current year | 1 | | 1.98 |
| 1 year | 1 | | 2.09 |
| 3 years | 0.37 | | 2.09 |
| 5 years | 0.37 | | 2.71 |
| 10 years | 0.37 | | 4 |
Monthly variations
Annual variations
| 2026 | -35.33% | ||
| 2025 | +232.34% | ||
| 2024 | -53.90% | ||
| 2023 | -6.84% | ||
| 2022 | -52.24% | ||
| 2021 | +39.20% | ||
| 2020 | +97.75% | ||
| 2019 | -2.52% | ||
| 2018 | -57.53% | ||
| 2017 | -40.44% | ||
| 2016 | -11.95% | ||
| 2015 | +9.92% | ||
| 2014 | +3.61% | ||
| 2013 | +14.65% | ||
| 2012 | -45.96% | ||
| 2011 | -30.25% | ||
| 2010 | +96.93% | ||
| 2009 | +138.98% | ||
| 2008 | +331.71% | ||
| 2007 | +54.72% | ||
| 2006 | -14.52% | ||
| 2005 | -79.47% | ||
| 2004 | +9.42% | ||
| 2003 | -10.97% | ||
| 2002 | -66.30% | ||
| 2001 | -38.67% | ||
| 2000 | -15.49% | ||
| 1999 | -48.92% | ||
| 1998 | -8.55% | ||
| 1997 | +103.57% | ||
| 1996 | +796.00% | ||
| 1995 | +56.25% | ||
| 1994 | -74.60% | ||
| 1993 | -19.23% | ||
| 1992 | -4.88% |
- Stock Market
- Stocks
- LCTX Stock
- Quotes Lineage Cell Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
